[go: up one dir, main page]

AU2001286091A1 - Methods for identifying modulators of protein interactions - Google Patents

Methods for identifying modulators of protein interactions

Info

Publication number
AU2001286091A1
AU2001286091A1 AU2001286091A AU8609101A AU2001286091A1 AU 2001286091 A1 AU2001286091 A1 AU 2001286091A1 AU 2001286091 A AU2001286091 A AU 2001286091A AU 8609101 A AU8609101 A AU 8609101A AU 2001286091 A1 AU2001286091 A1 AU 2001286091A1
Authority
AU
Australia
Prior art keywords
methods
protein interactions
identifying modulators
modulators
identifying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001286091A
Other languages
English (en)
Inventor
Christine Ellis
Ian Donald Hiles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2001286091A1 publication Critical patent/AU2001286091A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/02Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001286091A 2000-09-12 2001-09-12 Methods for identifying modulators of protein interactions Abandoned AU2001286091A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0022333.9 2000-09-12
GB0022333A GB0022333D0 (en) 2000-09-12 2000-09-12 Methods for identifying modulators of protein interactions
PCT/GB2001/004094 WO2002022862A2 (fr) 2000-09-12 2001-09-12 Methodes d'identification de modulateurs d'interactions de proteines

Publications (1)

Publication Number Publication Date
AU2001286091A1 true AU2001286091A1 (en) 2002-03-26

Family

ID=9899292

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001286091A Abandoned AU2001286091A1 (en) 2000-09-12 2001-09-12 Methods for identifying modulators of protein interactions

Country Status (3)

Country Link
AU (1) AU2001286091A1 (fr)
GB (1) GB0022333D0 (fr)
WO (1) WO2002022862A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003211261A1 (en) 2002-03-01 2003-09-16 Takeda Chemical Industries, Ltd. Antidepressant
WO2005083436A1 (fr) * 2004-02-26 2005-09-09 Bayer Healthcare Ag Methodes diagnostiques et therapeutiques destinees au traitement de maladies associees a la kinase 1 liee a l'integrine (ilk1)
WO2005083437A1 (fr) * 2004-02-26 2005-09-09 Bayer Healthcare Ag Methodes diagnostiques et therapeutiques destinees au traitement de maladies associees a la kinase 2 liee a l'integrine (ilk2)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2239151C (fr) * 1995-12-21 2011-03-29 Shoukat Dedhar Kinase liee a une integrine, inhibiteurs de cette kinase, traitement medical faisant appel a ces inhibiteurs, therapie genique et inhibiteurs du type pseudo-substrats
EP0876483A1 (fr) * 1996-01-26 1998-11-11 HSC Research and Development Limited Partnership Acides nucleiques et proteines lies a la maladie d'alzheimer et leurs utilisations

Also Published As

Publication number Publication date
WO2002022862A2 (fr) 2002-03-21
GB0022333D0 (en) 2000-10-25
WO2002022862A3 (fr) 2003-01-16

Similar Documents

Publication Publication Date Title
AU2001234608A1 (en) Methods for analysis of gene expression
AU2002316137A1 (en) Method of determining protein interaction inhibitors
AUPR392301A0 (en) Protein phosphatase inhibitors
AU5468499A (en) 3-methylidenyl-2-indolinone modulators of protein kinase
AU2002303584A1 (en) Method for identifying comparable instruments
AU2001241075A1 (en) Method of anticipating interaction between proteins
AU2002338428A1 (en) Methods and systems for identifying proteins
AU2001275007A1 (en) Methods of testing materials
AU2002364124A1 (en) Methods for identifying modulators of apoptosis
AU5551299A (en) Method of identifying proteins
AU2002244071A1 (en) Expression system for seed proteins
AU2001271841A1 (en) Methods for identifying combinations of drugs
AU2002214286A1 (en) Method of profiling protein
AU2001226387A1 (en) Methods of identifying modulators of the fgf receptor
AU2002221740A1 (en) Method for analyzing proteins
AU2002364749A1 (en) Method for protein expression analysis
AU2001285252A1 (en) Analysis of binding interactions
AU2002246912A1 (en) Receptor-binding compounds and methods for identifying them
AU2002234793A1 (en) Protein data analysis
AU6947500A (en) Methods for identifying modulators of transcriptional activator protein interactions
AU2002341828A1 (en) Enhanced proteins and methods for their use
AU2001227708A1 (en) Methods for identifying inhibitors of neuronal degeneration
AU2001286091A1 (en) Methods for identifying modulators of protein interactions
AU2472501A (en) Methods for protein transfer
AU2001237633A1 (en) Method of identifying modulators of presenilin